Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)
Eugenio Cavalli, Alessia Bramanti, Rosella Ciurleo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 3, pp. 903-912
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
Otavio Cabral‐Marques, Gilad Halpert, Lena F. Schimke, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 117
Rheumatological complications of Covid 19
Hannah Zacharias, Shirish Dubey, Gouri Koduri, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 9, pp. 102883-102883
Open Access | Times Cited: 104
Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes
Ruchi Jain, Sathishkumar Ramaswamy, Divinlal Harilal, et al.
Computational and Structural Biotechnology Journal (2020) Vol. 19, pp. 153-160
Open Access | Times Cited: 85
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
Maria Sofia Basile, Eugenio Cavalli, James A. McCubrey, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 3, pp. 848-856
Open Access | Times Cited: 70
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
Otavio Cabral‐Marques, Guido Moll, Rusan Catar, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103310-103310
Closed Access | Times Cited: 35
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
Dennyson Leandro M. Fonseca, Igor Salerno Filgueiras, Alexandre H. C. Marques, et al.
npj Aging (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19
Tania Islam, Md Rezanur Rahman, Büşra Aydın, et al.
European Journal of Pharmacology (2020) Vol. 887, pp. 173594-173594
Open Access | Times Cited: 59
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?
Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis (2021) Vol. 48, Iss. 01, pp. 072-092
Open Access | Times Cited: 52
Systemic lupus erythematosus and varicella‐like rash following COVID‐19 in a previously healthy patient
Yasmine Slimani, Reda Abbassi, F. El Fatoiki, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 2, pp. 1184-1187
Open Access | Times Cited: 51
Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
Kenneth Maiese
Biomolecules (2023) Vol. 13, Iss. 5, pp. 816-816
Open Access | Times Cited: 21
The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
Kenneth Maiese
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L.
Ralitza Alexova, Simona Alexandrova, Stela Dragomanova, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3772-3772
Open Access | Times Cited: 19
Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
Lyubka Tancheva, Maria Cristina Petralia, Simona Miteva, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 852-852
Open Access | Times Cited: 41
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature
Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis (2021) Vol. 48, Iss. 01, pp. 055-071
Open Access | Times Cited: 38
Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies
Antonio Cristiano, Valentina Fortunati, Fabio Cherubini, et al.
Clinical Rheumatology (2021) Vol. 40, Iss. 7, pp. 2939-2945
Open Access | Times Cited: 35
Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection
Eugenio Cavalli, Maria Cristina Petralia, Maria Sofia Basile, et al.
International Journal of Molecular Medicine (2020)
Open Access | Times Cited: 37
Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review
Akram Yarmohammadi, Mostafa Yarmohammadi, Sajad Fakhri, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173620-173620
Open Access | Times Cited: 33
SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets
Yue Li, Ashley Duche, Michael R. Sayer, et al.
BMC Genomics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Therapeutic Potential of Alpha-Lipoic Acid in Viral Infections, including COVID-19
Stela Dragomanova, Simona Miteva, Ferdinando Nicoletti, et al.
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1294-1294
Open Access | Times Cited: 32
NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases
Cinzia Sindona, Giovanni Schepici, Valentina Contestabile, et al.
Medicina (2021) Vol. 57, Iss. 6, pp. 604-604
Open Access | Times Cited: 28
Venous thromboembolism in the era of COVID-19
Konstantinos G. Kyriakoulis, Damianos G. Kokkinidis, Ioanna A Kyprianou, et al.
Phlebology The Journal of Venous Disease (2020) Vol. 36, Iss. 2, pp. 91-99
Open Access | Times Cited: 32
COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases
Katja Lakota, Katja Perdan Pirkmajer, Alojzija Hočevar, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 25
A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes’ interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19
Jun Ding, David Earl Hostallero, Mohamed Reda El Khili, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 3, pp. e1008810-e1008810
Open Access | Times Cited: 25
The Role of Antiphospholipid Antibodies in COVID-19
Maximilian Stelzer, Jörg Henes, Sebastian Saur
Current Rheumatology Reports (2021) Vol. 23, Iss. 9
Open Access | Times Cited: 25
A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?
Nina Kocivnik, Tomaž Velnar
Life (2022) Vol. 12, Iss. 11, pp. 1918-1918
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top